Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
12.9%
% of PSCH's 70 holdings also in SBIO
10.1%
% of SBIO's 89 holdings also in PSCH
Overlap by Weight
Sector Drift (PSCH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSCH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CORCEPT THERAPEUTICS INC | 3.3% | 4.2% | 3.3% |
 |
ALKERMES PLC | 3.2% | 3.6% | 3.2% |
|
KRYSTAL BIOTECH, INC. | 2.6% | 3.4% | 2.6% |
|
VERICEL CORPORATION | 1.8% | 2.0% | 1.8% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.5% | 1.7% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
PSCH Overweight Relative to SBIO
|
GLAUKOS CORP | 4.8% |
|
MERIT MEDICAL SYSTEMS INC | 3.8% |
|
HIMS & HERS HEALTH, INC. CLASS A | 3.6% |
|
INSPIRE MEDICAL SYSTEMS, INC. | 3.5% |
|
RADNET INC | 3.2% |
|
INTEGER HOLDINGS CORPORATION | 2.9% |
|
ADMA BIOLOGICS, INC. | 2.7% |
|
TG THERAPEUTICS INC | 2.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.6% |
|
ICU MEDICAL INC | 2.5% |
PSCH Underweight Relative to SBIO
|
ARCELLX, INC. | -3.2% |
|
CRINETICS PHARMACEUTICALS INC | -3.1% |
|
AVIDITY BIOSCIENCES INC | -2.7% |
|
PTC THERAPEUTICS INC | -2.5% |
|
DENALI THERAPEUTICS INC. | -2.3% |
 |
MERUS N.V. | -2.2% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% |
|
ACADIA PHARMACEUTICALS INC | -2.1% |
|
AMICUS THERAPEUTICS INC | -2.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -1.9% |